These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 17641721)
1. Early clinical experience with leflunomide in uveitis. Roy M Can J Ophthalmol; 2007 Aug; 42(4):634. PubMed ID: 17641721 [No Abstract] [Full Text] [Related]
2. Leflunomide. Cohen SB; Iqbal I Int J Clin Pract; 2003 Mar; 57(2):115-20. PubMed ID: 12661795 [TBL] [Abstract][Full Text] [Related]
4. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis. Bartlett RR; Brendel S; Zielinski T; Schorlemmer HU Transplant Proc; 1996 Dec; 28(6):3074-8. PubMed ID: 8962190 [No Abstract] [Full Text] [Related]
5. Successful treatment of sarcoidosis with leflunomide. Majithia V; Sanders S; Harisdangkul V; Wilson JG Rheumatology (Oxford); 2003 May; 42(5):700-2. PubMed ID: 12709556 [No Abstract] [Full Text] [Related]
6. Vasculitis associated with the use of leflunomide. Macdonald J; Zhong T; Lazarescu A; Gan BS; Harth M J Rheumatol; 2004 Oct; 31(10):2076-8. PubMed ID: 15468379 [TBL] [Abstract][Full Text] [Related]
7. Leflunomide, a valid and safe drug for the treatment of chronic anterior uveitis associated with juvenile idiopathic arthritis. Molina C; Modesto C; Martín-Begué N; Arnal C Clin Rheumatol; 2013 Nov; 32(11):1673-5. PubMed ID: 23828309 [No Abstract] [Full Text] [Related]
8. Treatment of severe psoriasis and psoriatic arthritis with leflunomide. Reich K; Hummel KM; Beckmann I; Mössner R; Neumann C Br J Dermatol; 2002 Feb; 146(2):335-6. PubMed ID: 11903256 [No Abstract] [Full Text] [Related]
9. Leflunomide in rheumatoid arthritis: recommendations through a process of consensus. Maddison P; Kiely P; Kirkham B; Lawson T; Moots R; Proudfoot D; Reece R; Scott D; Sword R; Taggart A; Thwaites C; Williams E Rheumatology (Oxford); 2005 Mar; 44(3):280-6. PubMed ID: 15657072 [TBL] [Abstract][Full Text] [Related]
10. Leflunomide: new indication. In psoriatic rheumatism: too many risks, too little efficacy. Prescrire Int; 2005 Aug; 14(78):123-6. PubMed ID: 16106593 [TBL] [Abstract][Full Text] [Related]
15. [Emergence of new therapeutic agents for collagen diseases and some of the problems]. Kawai S Nihon Naika Gakkai Zasshi; 2003 Oct; 92(10):1990-6. PubMed ID: 14621590 [No Abstract] [Full Text] [Related]
16. Leflunomide for the treatment of systemic lupus erythematosus: comment on the article by McMurray. Barthel HR Arthritis Rheum; 2001 Oct; 45(5):472. PubMed ID: 11642648 [No Abstract] [Full Text] [Related]